Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
job ratings (see below graph) for JNJ
latest headlines for company on cafepharma
JNJ Moved to Restructure Its Medical Devices Business in 3Q16
Market Realist
Fri, 10/21/16 - 10:23 pm
Tags:
JNJ
,
devices
,
restructuring
3 reasons Johnson & Johnson picked Tampa for a global services center (Video)
Bizjournals.com
Thu, 10/20/16 - 03:34 pm
Tags:
JNJ
,
Tampa
,
Florida
FDA to withdraw approval of Lannett's generic ADHD drug
Bizjournals.com
Thu, 10/20/16 - 09:30 am
Tags:
FDA
,
Lannett
,
generics
,
ADHD
,
Concerta
,
JNJ
,
Janssen
The 3 Biggest Stories From Johnson & Johnson's Third-Quarter Report
Motley Fool
Thu, 10/20/16 - 09:21 am
Tags:
JNJ
,
earnings
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
Tags:
JNJ
,
biosimilars
,
Remicade
,
Pfizer
,
rheumatoid arthritis
J&J posts earnings beat, and says pharma future bright, despite threat to Remicade
Yahoo/Reuters
Tue, 10/18/16 - 10:46 am
Tags:
JNJ
,
earnings
,
Remicade
Clinical trial roundup 2015 (infographic)
CP Wire
Tue, 10/18/16 - 10:01 am
Tags:
clinical trials
,
AstraZeneca
,
Roche
,
JNJ
,
oncology
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Tags:
Pfizer
,
Remicade
,
biosimilars
,
Inflectra
,
JNJ
,
rheumatoid arthritis
3 Figures That Matter Most When Johnson & Johnson Reports Its 3rd-Quarter Results
Motley Fool
Fri, 10/14/16 - 11:48 am
Tags:
JNJ
,
earnings
Could J&J's recent news about its rheumatoid arthritis and Crohn's disease drugs threaten AbbVie's Humira?
Motley Fool
Thu, 10/13/16 - 11:05 am
Tags:
JNJ
,
rheumatoid arthritis
,
Crohn's Disease
,
AbbVie
,
Humira
,
sirukumab
Piramal picks up J&J drugs in strategic move
BioPharma Dive
Wed, 10/12/16 - 11:32 am
Tags:
Piramal Healthcare
,
India
,
JNJ
,
Sublimaze
,
Sufenta
,
Dipidolor
,
Rapifen
,
Hypnomidate
Johnson & Johnson Earnings Preview
Seeking Alpha
Wed, 10/12/16 - 11:25 am
Tags:
JNJ
,
earnings
U.S. FDA clears Xarelto blood thinner despite faulty trial device
Yahoo/Reuters
Tue, 10/11/16 - 09:38 pm
Tags:
FDA
,
Xarelto
,
blood thinners
,
JNJ
AstraZeneca conducts fourth sale this week
BioPharma Dive
Fri, 10/7/16 - 10:27 pm
Tags:
AstraZeneca
,
JNJ
,
Cilag
,
Rhinocort Aqua
This Looks to Be Johnson & Johnson's Next Blockbuster Drug
Motley Fool
Wed, 10/5/16 - 09:40 am
Tags:
JNJ
,
psoriasis
,
guselkumab
J&J warns diabetic patients: Insulin pump vulnerable to hacking
Yahoo/Reuters
Wed, 10/5/16 - 09:32 am
Tags:
JNJ
,
diabetes
,
insulin pumps
,
devices
,
device security
,
Animas OneTouch
J&J psoriasis drug tops placebo, Humira in late stage study
Yahoo/Reuters
Mon, 10/3/16 - 09:42 pm
Tags:
JNJ
,
psoriasis
,
Humira
,
AbbVie
,
guselkumab
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Tags:
Big Pharma
,
patents
,
biosimilars
,
Novartis
,
Amgen
,
Biogen
,
Sanofi
,
Merck
,
Eli Lilly
,
Pfizer
,
JNJ
Which drugmakers have the healthiest presence on social media?
Medical Marketing and Media
Wed, 09/28/16 - 10:40 am
Tags:
social media
,
Eli Lilly
,
JNJ
,
Boehringer Ingelheim
,
Novo Nordisk
J&J Finally Returning to Its Roots in Diversity?
Yahoo/GuruFocus
Mon, 09/26/16 - 03:27 pm
Tags:
JNJ
,
diversification
Pages
« first
‹ previous
…
81
82
83
84
85
86
87
88
89
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.